The lead nanobody, 2R215, was then tested against pathogenic ETEC strains expressing other adhesins that are commonly isolated from patients with ETEC-associated diarrheal diseases, including CS1, CS3, CS5, CS6, and CS2111,13. The gene discussed is CSHL1; the disease is diarrheal disease.